Our Company

Medical Essentials forms the foundation of health care delivery, producing billions of devices each year that ensure safe medication administration and support accurate diagnostics. “Jack” Howe joins BD and becomes integral to developing sterility control procedures and refining the process for manufacturing disposable syringes and needles. 1962 BD launched the first mass production of syringes and needles. BD recalled and tested the syringes in question, and revealed sterile particulates in 0.013 percent of the products.

Innovative solutions to power your diagnostics and research

• In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.
• Explore a variety of tools for your multicolor flow cytometry, from panel design to selection tools—an array of aids to support your research.
• As one of the largest global medical technology companies, we develop solutions that improve diagnostics, enhance care and transform lives around the world.
• Use a variety of training courses for instruments and applications to take full advantage of the capabilities of BD products.

1954 Production of the first disposable syringes to be used in the Salk Polio vaccine trial takes place. 1988 BD launched the first safety engineered syringe. 1991 BD opens a central distribution center in Temsee, Belgium to ship medical products across Europe, the middle east, and Africa. 1995 A joint venture was established in China to produce medical products for China. 1995 A joint venture was established in China to produce medical products for China.\r\n 2007 BD participates in PEPFAR, the U.S. government’s global effort to combat HIV and the largest global health program devoted to a single disease.

In April 2016, the Occupational Safety and Health Administration fined BD US$112,700 for safety violations. Pfitzer et al. (2013) identify BD’s development of a needleless injection system as an example of leading businesses’ role in creating shared value. The company’s line of plastic conical screwtop test tubes, known as ‘Falcon tubes’, is popular and the term is sometimes used as a generic term for such tubes.

By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare.

It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. Fill out the form to receive updates khelaghor-bangladesh.com on our latest products and innovations, exclusive promotions, educational tours, and other exciting news. Designed and validated for use with cell suspensions, whole blood and tissue pieces.

1999 The world’s shortest, thinnest insulin pen needle is introduced. 2007 BD AutoShield™ needle is launched. 2015 BD became the first to integrate IV pumps with electronic health records. 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.

Sign Up for Job Alerts

1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles. 1972 BD launched the first florescence-activated cell sorter. 1981 A new plant is built in Plymouth, England to manufacture BD Vacutainer® system products and serve a growing European market. 1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan.

Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. At BD, we believe that people are at the heart of every breakthrough, solution, and step forward. BD can help you improve surgical outcomes and lower costs

In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion. This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products.

A unique ecosystem to collaborate on flow cytometry panel design, improve cytometer efficiency and manage your laboratory. Explore a variety of tools for your multicolor flow cytometry, from panel design to selection tools—an array of aids to support your research. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.